Attention AACR Annual Meeting 2018 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 67 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 64 65 66 67 presentations: 1 to 25 of 1671
Autophagy overview and roles in tumor cell death
Andrew M. Thorburn
Univ. of Colorado Denver, Aurora, CO, United States
from AACR Annual Meeting 2018 on April 14, 2018 10:15 AM-12:15 PM
Autophagy in tumor progression to metastasis
Kay F Macleod
Univ. of Chicago Ben May Dept. for Cancer Res., Chicago, IL, United States
from AACR Annual Meeting 2018 on April 14, 2018 10:15 AM-12:15 PM
Autophagy in the tumor immune response
Lorenzo Galluzzi
Weill Cornell Medical College, New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 10:15 AM-12:15 PM
Targeting autophagy in the clinic and next generation autophagy drugs
Ravi K. Amaravadi
Univ. of Pennsylvania, Philadelphia, PA, United States
from AACR Annual Meeting 2018 on April 14, 2018 10:15 AM-12:15 PM
Next generation humanized mice in cancer research
Leonard D Shultz
The Jackson Laboratory Cancer Ctr., Bar Harbor, ME, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Targeting the innate immune response in models of leukemia and lymphoma
David M Weinstock
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Understanding clonal complexity of human hematologic malignancies by single-cell genomics and PDX modeling
Fumihiko Ishikawa
RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Integrated Genomics for PDX
Carol J Bult
The Jackson Laboratory, Bar Harbor, ME, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Overview of thyroid cancer: Epidemiology to state-of art standard of care
Steven I. Sherman
UT MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Cancer genomics: Well to poorly differentiated thyroid carcinoma
James A Fagin
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Discovering targeted therapies of thyroid cancer using drosophila models
Ross L Cagan
Mount Sinai School of Medicine, New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
BRAF-targetedtherapy and mechanisms of resistance in thyroid cancer clinical trials
Manisha H Shah
Ohio State Univ. Comp. Cancer Ctr., Columbus, OH, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Emerging novel RET-Targeted therapy in thyroid cancer
Lori J Wirth
Massachusetts General Hospital, Boston, MA, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Using the Cancer Genome Interpreter for gene panel design and variant interpretation
David Tamborero
Univ. of Pompeu Fabra, Barcelona, Spain
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Using cBioPortal and OncoKB to identify cancer driver alterations and interpret those which are clinically actionable
Debyani Chakravarty
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
MatchMiner: A computational platform for matching patient-specific genomic profiles to precision medicine clinical trials
Catherine A. Del Vecchio Fitz
Dana Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
CIViC: Best practices for curating germline and somatic cancer variants
Obi Lee Griffith
Washington University School of Medicine, Saint Louis, MO, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Intraoperative tumor grading through rapid lipidomic profiling with picosecond infra red laser mass spectrometry (PIRL-MS)
Arash Zarrine-Afsar
Univ. of Toronto, Toronto, ON, Canada
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Application of mass spectrometry in CANscript: A patient-derived ex-vivo platform for biomarker discovery in cancer
Aaron J Goldman
Harvard Medical School, Cambridge, MA, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Urinary prostaglandin E2 metabolites as biomarkers in cancer
Ginger L Milne
Vanderbilt University Medical Center, Nashville, TN, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Recent advances in mass spectrometry-based oncology biomarker discovery
Ahmed M Aman
Ontario Inst. for Cancer Research, Toronto, ON, Canada
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Understanding and targeting RNA splicing factor mutations in cancer
Omar Abdel-Wahab
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
The functional impact of alternative splicing in cancer
Eduardo Eyras
Pompeu Fabra University, Barcelona, Spain
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Targeting RNA post-transcriptional processing by inhibition of protein arginine methyltrasnferases
Ernesto Guccione
Icahn School of Medicine at Mount Sinai, New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
From genetics to cancer therapeutics: New frontiers in the RNAworld
Thomas F Westbrook
Baylor College of Medicine, Houston, TX, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
<< first | < prev page: of 67 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 64 65 66 67 presentations: 1 to 25 of 1671